Implanted Miniature Telescope has FDA approval broadened for AMD- VisionCare Ophthalmic Technologies

VisionCare Ophthalmic Technologies, Inc. a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), announced the FDA approved the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) for use in patients living with bilateral end-stage age-related macular degeneration who are age 65 or older. The telescope implant is the only FDA approved surgical device for end-stage AMD and is Medicare eligible.

The telescope implant was previously approved by the FDA for patients greater than or equal to 75 years of age. FDA approval to expand access to those age 65 and older was based on clinical data provided by the pivotal safety and efficacy study, IMT-002, and long-term studies IMT-002-LTM and IMT-002-LTME, which followed patients to 5 and 8 years, respectively.